News
AvevoRx ANNOUNCES ENTRY INTO ALPHA-1 PROTEINAISE INHIBITOR MARKET, INCREASING THERAPEUTIC ACCESS FOR PATIENTS WITH RARE FORM OF CONGENITAL EMPHYSEMA
February 24, 2023
“AvevoRx brings the knowledge and infrastructure to provide services and programs typically expected of much bigger pharmacies while leveraging our adaptability and commitment to delivering
AvevoRx ANNOUNCES ACQUISITION OF ACCESS TO CARE, LLC PHARMACY
February 24, 2023
Greensboro, N.C. – February 28, 2023 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, has announced its acquisition of Access to Care,
AvevoRX ENTERS BLEEDING DISORDERS MARKET WITH AN INFUSION PHARMACY PROGRAM TO SERVE PATIENTS WITH HEMOPHILIA & RELATED DISEASES
December 5, 2022
For this niche patient population, the program offers a refreshing solution to the lack of customizable, specialty pharmacy services currently available Greensboro, N.C. – December
AvevoRX NAMES PEG GRUENEMEIER DIRECTOR OF CLINICAL SERVICES & QUALITY
November 16, 2022
Infusion-industry nursing veteran joins the company as it forges rapid, national expansion AvevoRx, a national, independent provider of specialty infusion pharmacy services, has named Peg
